Altium Capital Management as of March 31, 2025
Portfolio Holdings for Altium Capital Management
Altium Capital Management holds 23 positions in its portfolio as reported in the March 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Zevra Therapeutics Com New (ZVRA) | 22.0 | $9.6M | 1.3M | 7.49 | |
| Alnylam Pharmaceuticals Put Option (ALNY) | 15.4 | $6.8M | 25k | 270.02 | |
| Evolus (EOLS) | 8.1 | $3.6M | 296k | 12.03 | |
| Xtant Med Hldgs Com New (XTNT) | 7.8 | $3.4M | 7.3M | 0.47 | |
| Avadel Pharmaceuticals Com Shs (AVDL) | 7.5 | $3.3M | 419k | 7.83 | |
| Xenon Pharmaceuticals Call Option (XENE) | 5.3 | $2.3M | 70k | 33.55 | |
| Contineum Therapeutics Cl A (CTNM) | 4.8 | $2.1M | 304k | 6.98 | |
| Profound Med Corp Com New (PROF) | 4.8 | $2.1M | 361k | 5.82 | |
| Logicmark Com New (LGMK) | 4.4 | $1.9M | 98M | 0.02 | |
| Essa Pharma Com New (EPIX) | 3.8 | $1.7M | 1.1M | 1.58 | |
| Skye Bioscience Com New (SKYE) | 3.3 | $1.4M | 905k | 1.59 | |
| Alpha Cognition Com New (ACOG) | 2.1 | $898k | 177k | 5.06 | |
| Rezolute Com New (RZLT) | 2.0 | $882k | 304k | 2.90 | |
| Nektar Therapeutics | 1.6 | $715k | 1.1M | 0.68 | |
| Anteris Technologies Global (AVR) | 1.4 | $614k | 169k | 3.64 | |
| Larimar Therapeutics (LRMR) | 1.3 | $587k | 273k | 2.15 | |
| Sharps Technology Com New | 1.3 | $560k | 19M | 0.03 | |
| Promis Neurosciences Com New (PMN) | 0.9 | $399k | 574k | 0.70 | |
| Envveno Medical (NVNO) | 0.7 | $324k | 123k | 2.63 | |
| Intelligent Bio Solutions In (INBS) | 0.5 | $215k | 149k | 1.44 | |
| Karyopharm Therapeutics Com New (KPTI) | 0.4 | $185k | 49k | 3.74 | |
| Sunshine Biopharma (SBFM) | 0.2 | $96k | 51k | 1.91 | |
| Better Choice Com New (SRXH) | 0.2 | $67k | 39k | 1.72 |
